FDA Approved: REPAGLINIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for repaglinide submitted by Rising Pharma Holdings, Inc., resulting in changes to the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Repaglinide (Repaglinide)

Snippet

SUPPL AP for REPAGLINIDE (REPAGLINIDE)